Kidney nonprocurement in deceased donors with acute kidney injury.

acute kidney injury creatinine deceased donor donor selection kidney transplantation organ donation organ procurement

Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
11 2022
Historique:
revised: 12 07 2022
received: 13 04 2022
accepted: 29 07 2022
pubmed: 5 8 2022
medline: 15 12 2022
entrez: 4 8 2022
Statut: ppublish

Résumé

Acute kidney injury (AKI) is common in deceased organ donors and is associated with high rates of kidney discard by transplant centers. High discard rates may consequently drive nonprocurement of these kidneys by organ procurement organizations. We aimed to study the relationship between donor AKI and kidney nonprocurement. Using U.S. registry data, we identified donors with at least one organ recovered from 2008 to 2018. We compared characteristics of donors with no kidneys procured across AKI stages, and used multivariable logistic regression to evaluate the relationship between AKI severity and kidney nonprocurement. Overall 14 543 kidneys from 7620 donors were not procured, among which 93% were from donors with AKI. For 6945 donors with no kidneys procured but an extrarenal organ recovered, most had stage 3 (51%), followed by stage 1 (27%) and stage 2 AKI (15%). Nonprocured stage 3 donors were the youngest and had the lowest Kidney Donor Risk Index of all nonprocured donors. Adjusted odds of kidney nonprocurement were 1.14 (95%CI 1.02-1.27) for stage 1, 1.25 (95%CI 1.12-1.41) for stage 2, and 10.37 (95%CI 9.30-11.56) for stage 3 donors, compared to non-AKI donors. Among donors with minimum creatinine <1.5 mg/dl, stage 2 and 3 AKI were still associated with significantly higher odds of nonprocurement. AKI severity is a strong risk factor for kidney nonprocurement. Efforts to address the organ shortage should focus on encouraging procurement and utilization of kidneys from deceased donors with severe AKI, given the large and rising prevalence of donor AKI and excellent transplant outcomes with these kidneys.

Sections du résumé

BACKGROUND
Acute kidney injury (AKI) is common in deceased organ donors and is associated with high rates of kidney discard by transplant centers. High discard rates may consequently drive nonprocurement of these kidneys by organ procurement organizations. We aimed to study the relationship between donor AKI and kidney nonprocurement.
METHODS
Using U.S. registry data, we identified donors with at least one organ recovered from 2008 to 2018. We compared characteristics of donors with no kidneys procured across AKI stages, and used multivariable logistic regression to evaluate the relationship between AKI severity and kidney nonprocurement.
RESULTS
Overall 14 543 kidneys from 7620 donors were not procured, among which 93% were from donors with AKI. For 6945 donors with no kidneys procured but an extrarenal organ recovered, most had stage 3 (51%), followed by stage 1 (27%) and stage 2 AKI (15%). Nonprocured stage 3 donors were the youngest and had the lowest Kidney Donor Risk Index of all nonprocured donors. Adjusted odds of kidney nonprocurement were 1.14 (95%CI 1.02-1.27) for stage 1, 1.25 (95%CI 1.12-1.41) for stage 2, and 10.37 (95%CI 9.30-11.56) for stage 3 donors, compared to non-AKI donors. Among donors with minimum creatinine <1.5 mg/dl, stage 2 and 3 AKI were still associated with significantly higher odds of nonprocurement.
CONCLUSIONS
AKI severity is a strong risk factor for kidney nonprocurement. Efforts to address the organ shortage should focus on encouraging procurement and utilization of kidneys from deceased donors with severe AKI, given the large and rising prevalence of donor AKI and excellent transplant outcomes with these kidneys.

Identifiants

pubmed: 35924345
doi: 10.1111/ctr.14788
pmc: PMC9771943
mid: NIHMS1828675
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14788

Subventions

Organisme : NIDDK NIH HHS
ID : R01DK093770
Pays : United States
Organisme : HRSA HHS
ID : 234-2005-370011C
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK126739
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL085757
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL085757
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK133729
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR001874
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK116066
Pays : United States
Organisme : NIDDK NIH HHS
ID : UH3 DK114866
Pays : United States
Organisme : NIMHD NIH HHS
ID : R01 MD014161
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK114893
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01DK106962
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2TR001874
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK114893
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK126739
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK130058
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK130058
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK093770
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK106962
Pays : United States
Organisme : NIDDK NIH HHS
ID : UH3DK114866
Pays : United States

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Kidney Int. 2018 Jul;94(1):187-198
pubmed: 29735310
Transplantation. 2019 Sep;103(9):e263-e272
pubmed: 31205261
Am J Transplant. 2012 Aug;12(8):2098-105
pubmed: 22758926
JAMA Netw Open. 2020 Jan 3;3(1):e1918634
pubmed: 31913491
Clin J Am Soc Nephrol. 2019 Nov 7;14(11):1634-1641
pubmed: 31624140
Clin Transplant. 2018 Dec;32(12):e13431
pubmed: 30347464
Am J Transplant. 2009 Feb;9(2):367-73
pubmed: 19178415
Am J Transplant. 2015 Aug;15(8):2143-51
pubmed: 25808278
Transplantation. 2019 Aug;103(8):1714-1721
pubmed: 30451742
Am J Transplant. 2015 Jun;15(6):1623-31
pubmed: 25762442
Ren Fail. 2019 Nov;41(1):167-174
pubmed: 30909784
Am J Transplant. 2020 Jan;20 Suppl s1:509-541
pubmed: 31898414
Clin J Am Soc Nephrol. 2017 Jul 27;:
pubmed: 28751577
Kidney Int. 2019 Jan;95(1):199-209
pubmed: 30470437
Am J Kidney Dis. 2017 Jul;70(1):153-154
pubmed: 28416320
Nephrology (Carlton). 2019 Dec;24(12):1296-1303
pubmed: 31081209
Am J Transplant. 2022 Mar;22(3):898-908
pubmed: 34897982
Am J Kidney Dis. 2020 Nov;76(5):743-746
pubmed: 32479923
Transplantation. 2009 Jul 27;88(2):231-6
pubmed: 19623019
JAMA. 2007 Jul 25;298(4):430-7
pubmed: 17652297
Eur J Heart Fail. 2012 Jun;14(6):597-604
pubmed: 22505396
Kidney Int Rep. 2021 Jun 19;6(9):2463-2467
pubmed: 34514207
MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):289-293
pubmed: 29543788
Adv Chronic Kidney Dis. 2017 Jul;24(4):194-204
pubmed: 28778358
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Am J Transplant. 2020 Dec;20(12):3413-3425
pubmed: 32342627
Am J Transplant. 2016 Nov;16(11):3086-3092
pubmed: 27172238
Clin J Am Soc Nephrol. 2022 Apr;17(4):565-567
pubmed: 35197257
Clin Transplant. 2021 Dec;35(12):e14465
pubmed: 34514643
Ann Surg. 2022 Dec 1;276(6):e982-e990
pubmed: 33196484
Transplantation. 2020 Aug;104(8):1553-1559
pubmed: 32732831
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):904-906
pubmed: 31015260
JAMA Netw Open. 2019 Aug 2;2(8):e1910312
pubmed: 31469394
JAMA Netw Open. 2020 Oct 1;3(10):e2019209
pubmed: 33021646

Auteurs

Kathleen Yu (K)

Department of Medicine, Division of Nephrology, Columbia University Medical Center, New York, New York, USA.

Syed A Husain (SA)

Department of Medicine, Division of Nephrology, Columbia University Medical Center, New York, New York, USA.

Kristen King (K)

Department of Medicine, Division of Nephrology, Columbia University Medical Center, New York, New York, USA.

Jacob S Stevens (JS)

Department of Medicine, Division of Nephrology, Columbia University Medical Center, New York, New York, USA.

Chirag R Parikh (CR)

Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Sumit Mohan (S)

Department of Medicine, Division of Nephrology, Columbia University Medical Center, New York, New York, USA.
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH